Skip to content
In 2022, Congress enacted the Food and Drug Omnibus Reform Act, also known as FDORA, which requires drug sponsors to submit diversity action plans […]
Without clinical trial diversity, we’re ‘losing a lot of opportunity’ Read More »
Photo: BIO’s Emily Wheeler (second from left) with Jean Mwale, Amputee Coalition regional ambassador and sepsis survivor (right), at the Amputee Coalition 2023 National
How amputees give voice to AMR Read More »
The U.S. Food and Drug Administration (FDA) on August 4 approved the first oral medication, Zurzuvae (zuranolone), for the treatment of post-partum depression (PPD).
Science and compassion merge to help women handle post-partum depression Read More »
If you take a “blood thinning” medication like Warfarin and then require an urgent procedure or emergency surgery, what can doctors do to protect
FDA approves new solution for quickly reversing impact of blood thinners Read More »
The Centers for Disease Control and Prevention (CDC) added a recently approved monoclonal antibody (mAb) for respiratory syncytial virus (RSV) prevention to the list
CDC recommends routine use of RSV monoclonal antibody for infants Read More »
Merck on July 27 announced positive Phase 3 results for a new pneumococcal conjugate vaccine, which targets several varieties of bacteria that cause pneumococcal pneumonia.
Merck’s pneumococcal vaccine for adults shows promise in Phase 3 trial Read More »
Every 3 seconds, one person worldwide develops dementia. With an estimated 5.9 million Americans living with dementia today, and 44 million people living with
The World Health Organization (WHO) reports that routine vaccination rates among children have increased, although there’s room for improvement. According to UNICEF and WHO
Routine immunization among kids is improving Read More »
Voters hold a favorable opinion of biotechnology and support streamlined government regulatory processes to allow faster approval of biotech innovations in agriculture, according to
Creative individuals are spearheading imaginative approaches as biotech battles cancer, the leading cause of death worldwide. Profiles of leaders from a cancer institute and
Innovators describe biotech advances against cancer in I am BIO videos Read More »
